 | Up a level |
Fasching, Peter A; Hack, Carolin C; Nabieva, Naiba; Maass, Nicolai; Aktas, Bahriye; Kümmel, Sherko; Thomssen, Christoph; Wolf, Christopher; Kolberg, Hans-Christian; Brucker, Cosima; Janni, Wolfgang; Dall, Peter; Schneeweiss, Andreas; Marme, Frederik; Sütterlin, Marc W; Ruebner, Matthias; Theuser, Anna-Katharin; Kellner, Sara; Hofmann, Nadine M; Böhm, Sybille; ... (2024). Prognostic impact of selection criteria of current adjuvant endocrine therapy trials NATALEE and monarchE in postmenopausal HRpos/HER2neg breast cancer patients treated with upfront letrozole. European journal of cancer, 209, p. 114239. Elsevier 10.1016/j.ejca.2024.114239
Hack, Carolin C; Maass, Nicolai; Aktas, Bahriye; Kümmel, Sherko; Thomssen, Christoph; Wolf, Christopher; Kolberg, Hans-Christian; Brucker, Cosima; Janni, Wolfgang; Dall, Peter; Schneeweiss, Andreas; Marme, Frederik; Ruebner, Matthias; Theuser, Anna-Katharin; Hofmann, Nadine M; Böhm, Sybille; Almstedt, Katrin; Kellner, Sara; Nabieva, Naiba; Gass, Paul; ... (2024). Correction: Long-term Follow-up and Safety of Patients after an Upfront Therapy with Letrozole for Early Breast Cancer in Routine Clinical Care - The PreFace Study. Geburtshilfe und Frauenheilkunde, 84(2) Thieme 10.1055/a-2314-3693
